Evolus, Inc.
EOLSDrug Manufacturers - Specialty & Generic
$7.52−1.51%As of Oct 29vs prior close
- Market cap
- $496.7M
- P/E (TTM)
- –
- From 52W high
- −19.14%
- EPS (LTM)
- -$0.51
- Revenue (LTM)
- $316.5M
- Net margin
- -10.85%
- Dividend yield
- 0.00%
Nomior Score
41
Steady ProfileSpeculativeBottom 31% of the scored universe
Growth64
Quality35
Value39
Momentum56
Resilience35
Growth
$316.5Mrevenue, LTM
YE18 $0LTM $316.5M
Connections
Revenue to profitQ2 YE26
The operating loss was 5% of revenue, narrower by 9 pts on a year.
Who owns it
2funds